Both in Biotechnology
Kodiak Sciences vs CG Oncology
Over the past year KOD returned +741.4% and CGON returned +47.6%; their daily moves had a correlation of 0.23.
KOD +741.4% CGON +47.6%Growth of $1, one year, split-adjusted
| Metric | KOD | CGON |
|---|---|---|
| Price | $99.87 | $63.82 |
| Market cap | $6.28B | $5.66B |
| Today | +5.95% | +0.89% |
| 1 month | +203.8% | −11.4% |
| 6 months | +131.7% | −5.7% |
| Year to date | +257.2% | +53.7% |
| 1 year | +590.7% | +56.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | −239.2% |
| Net margin | — | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 908.3× |
| Net cash | $125.9M | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 214.5% | 47.0% |
| Short % of float | 31.7% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).